CELLDEX THERAPEUTICS INC NEW - COM (CLDX)

CUSIP: 15117B103

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COM
Total 13F shares
73,890,230
Share change
-7,882,572
Total reported value
$182,511,997
Put/Call ratio
169%
Price per share
$2.47
Number of holders
125
Value change
-$22,290,534
Number of buys
53
Number of sells
57

Quarterly Holders Quick Answers

What is CUSIP 15117B103?
CUSIP 15117B103 identifies CLDX - CELLDEX THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLDEX THERAPEUTICS INC NEW - COM (CLDX) as of Q2 2017

As of 30 Jun 2017, CELLDEX THERAPEUTICS INC NEW - COM (CLDX) was held by 125 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 73,890,230 shares. The largest 10 holders included VANGUARD GROUP INC, FMR LLC, BlackRock Inc., COLUMBIA WANGER ASSET MANAGEMENT LLC, KLP Enterprises, LLC, Meditor Group Ltd, NORTHERN TRUST CORP, STATE STREET CORP, FRONTIER CAPITAL MANAGEMENT CO LLC, and DEUTSCHE BANK AG\. This page lists 125 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.